Personalized medicine in diabetes: Unraveling the disease casualty of HNF1A and HNF4A gene coding variants of “unknown clinical significance” in two large Norwegian diabetes registries
We have established a reference group for the research planning and implementation monitoring at the KG Jebsen Diabetes Center. This reference group consists of both a scientific advisory board (Prof. Leif Groop, Lund University; Prof. Peter Arner, Karolinska Institute; Prof. Karen Temple, University of Southampton) and research end-users including a member from the Norwegian Diabetes Association. The end- users are invited to provide talks and to participate at our KG Jebsen meetings every 6 months, the next meeting being September 24, 2015. The users are also our patients, that most likely will have improved diagnosies and targeted treatment as benefits.